Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newspaper Article
|
NICHD ANNOUNCES RESULTS FROM PHASE III CLINICAL TRIAL FOR NORTH AMERICAN VACCINE'S DTaP VACCINEBusiness Wire, 1994-11-22, p.11221185COPYRIGHT 1994 Business Wire, Inc.Digital Resources/Online E-Resources |
|
2 |
Material Type: Newspaper Article
|
NORTH AMERICAN VACCINE ANNOUNCES NEW NIH RELEASE TO CLARIFY CLINICAL TRIAL RESULTSBusiness Wire, 1994-12-01, p.12011303COPYRIGHT 1994 Business Wire, Inc.Digital Resources/Online E-Resources |
|
3 |
Material Type: Newspaper Article
|
CLINICAL DATA ON INVESTIGATIONAL VACCINES PRESENTED AT 95TH GENERAL MEETING OF THE ASM IN WASHINGTON, DCBusiness Wire, 1995-05-24, p.5241163COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
|
4 |
Material Type: Newspaper Article
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART III OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
|
5 |
Material Type: Newspaper Article
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART V OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
|
6 |
Material Type: Newspaper Article
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART IV OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
|
7 |
Material Type: Newspaper Article
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART I OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newspaper Article
|
New Study Finds Almost 90% of Americans Expect to Face a Potentially Serious Health Condition in the Next Five YearsBusiness Wire, 2004-11-10, p.1Copyright Business Wire Nov 10, 2004Digital Resources/Online E-Resources |
|
9 |
Material Type: Newspaper Article
|
Preliminary Results from the Estracure Phase II Clinical TrialBusiness Wire, 2005-10-28COPYRIGHT 2005 Business Wire, Inc.Digital Resources/Online E-Resources |
|
10 |
Material Type: Newspaper Article
|
FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus GastroenteritisBusiness Wire, 2005-12-14COPYRIGHT 2005 Business Wire, Inc.Digital Resources/Online E-Resources |
|
11 |
Material Type: Newspaper Article
|
MCRI Granted FDA Approval to Conduct Reduced Anticoagulation Clinical Trial of On-X Prosthetic Heart Valve; Successful Completion Could Result in First-Ever Low-Dose Anticoagulation Therapy Recommendations for a Mechanical Heart ValveBusiness Wire, 2006-01-10COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
12 |
Material Type: Newspaper Article
|
Healthy Eating Trends: CPG Industry Taking Huge Leap Forward to Meet Consumers' Health and Wellness NeedsBusiness Wire, 2006-01-31, p.1Copyright Business Wire Jan 31, 2006Digital Resources/Online E-Resources |
|
13 |
Material Type: Newspaper Article
|
TYSABRI(R) Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory AuthoritiesBusiness Wire, 2006-03-01COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
14 |
Material Type: Newspaper Article
|
Antares Announces FDA Acceptance of Licensee's NDA; Transdermal Estradiol Gel is Antares' First ATD(TM) Gel Product Potentially Approvable By FDABusiness Wire, 2006-04-21COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
15 |
Material Type: Newspaper Article
|
IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder CancerBusiness Wire, 2006-06-13COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
16 |
Material Type: Newspaper Article
|
Daiichi Pure Chemicals, Toshiba and Toshiba Hokuto Electronics Agree to Develop DNA Chip Diagnostics Business; Aiming for Japan's First Practical Use of a DNA ChipBusiness Wire, 2006-07-11COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
17 |
Material Type: Newspaper Article
|
Needlestick Prevention Experts Identify Need for Better Safety Syringe Design, as Well as Improved Training and Reporting; `The Inviro Initiative' Gives Voice to Industry Thought Leaders and AdvocatesBusiness Wire, 2006-08-30, p.1Copyright Business Wire Aug 30, 2006Digital Resources/Online E-Resources |
|
18 |
Material Type: Newspaper Article
|
Hollis-Eden Pharmaceuticals Presents Positive Preclinical Data on Compounds Targeting Hormone Refractory Prostate CancerBusiness Wire, 2006-09-13COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
19 |
Material Type: Newspaper Article
|
New Phase III Data Showed Significant Glucose-Lowering Efficacy of JANUVIA(TM), an Investigational Medicine for Type 2 Diabetes, When Taken Simultaneously with MetforminBusiness Wire, 2006-09-14COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
|
20 |
Material Type: Newspaper Article
|
invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial ExecutionBusiness Wire, 2006-09-14COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |